Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury

Kidney International

Volumn 80, Issue 2, 2011, Pages 165-173

  Renner, Brandon ^a   Ferreira, Viviana P ^b   Cortes, Claudio ^b   Goldberg, Ryan ^a   Ljubanovic, Danica ^c   Pangburn, Michael K ^d   Pickering, Matthew C ^e   Tomlinson, Stephen ^f   Holland Neidermyer, Amanda ^a   Strassheim, Derek ^a   Holers, V Michael ^a   Thurman, Joshua M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c University of Zagreb School of Medicine   (Croatia)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

acute renal failure; complement; immunology and pathology

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEFICIENCY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY;

EID: 79959785187     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.115     Document Type: Article

References (25)

1. Muller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem 1988; 57: 321-347.
2. Thurman JM, Holers VM. The central role of the alternative complement pathway in human disease. J Immunol 2006; 176: 1305-1310. (Pubitemid 43134269)
3. Atkinson JP, Oglesby TJ, White D et al. Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor. Clin Exp Immunol 1991; 86 (Suppl 1): 27-30.
4. Pickering MC, de Jorge EG, Martinez-Barricarte R et al. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med 2007; 204: 1249-1256. (Pubitemid 46919861)
5. Smith RJ, Alexander J, Barlow PN et al. New approaches to the treatment of dense deposit disease. J Am Soc Nephrol 2007; 18: 2447-2456. (Pubitemid 47378860)
6. Alexander JJ, Quigg RJ. The simple design of complement factor H: looks can be deceiving. Mol Immunol 2006; 44: 123-132.
7. Meri S, Pangburn MK. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci USA 1990; 87: 3982-3986.
8. Pangburn MK, Pangburn KL, Koistinen V et al. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement. J Immunol 2000; 164: 4742-4751. (Pubitemid 30238075)
9. Sjoberg AP, Trouw LA, Clark SJ et al. The factor H variant associated with age-related macular degeneration (His-384) and the non-diseaseassociated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells. J Biol Chem 2007; 282: 10894-10900. (Pubitemid 47100772)
10. Thurman JM, Ljubanovic D, Edelstein CL et al. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 2003; 170: 1517-1523. (Pubitemid 36139523)
11. Thurman JM, Royer PA, Ljubanovic D et al. Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. J Am Soc Nephrol 2006; 17: 707-715.
12. Thurman JM, Lucia MS, Ljubanovic D et al. Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int 2005; 67: 524-530. (Pubitemid 40139844)
13. Thurman JM, Ljubanovic D, Royer PA et al. Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest 2006; 116: 357-368. (Pubitemid 43228352)
14. Pickering MC, Cook HT, Warren J et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 2002; 631: 424-428. (Pubitemid 35154455)
15. Rose KL, Paixao-Cavalcante D, Fish J et al. Factor I is required for the development of membranoproliferative glomerulonephritis in factor Hdeficient mice. J Clin Invest 2008; 118: 608-618. (Pubitemid 351206550)
16. Ferreira VP, Herbert AP, Hocking HG et al. Critical role of the C-terminal domains of factor h in regulating complement activation at cell surfaces. J Immunol 2006; 177: 6308-6316. (Pubitemid 44628849)
17. Ferreira VP, Pangburn MK. Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes. Blood 2007; 110: 2190-2192. (Pubitemid 47443939)
18. Zhou W, Farrar CA, Abe K et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000; 105: 1363-1371. (Pubitemid 30322402)
19. Huang Y, Qiao F, Atkinson C et al. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. J Immunol 2008; 181: 8068-8076.
20. Song H, He C, Knaak C et al. Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. J Clin Invest 2003; 111: 1875-1885. (Pubitemid 38057732)
21. Atkinson C, Song H, Lu B et al. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J Clin Invest 2005; 115: 2444-2453. (Pubitemid 41266206)
22. Xiao H, Schreiber A, Heeringa P et al. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007; 170: 52-64. (Pubitemid 47339189)
23. Watanabe H, Garnier G, Circolo A et al. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol 2000; 164: 786-794. (Pubitemid 30043702)
24. Farrar CA, Zhou W, Lin T et al. Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J 2006; 20: 217-226. (Pubitemid 44933168)
25. Molina H, Kinoshita T, Inoue K et al. A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. J Immunol 1990; 145: 2974-2983. (Pubitemid 20382569)